Jane Street
TXG icon

Jane Street’s 10x Genomics TXG Stock Holding History

Jane Street’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Buy
58,000
+47,500
+452% +$950K ﹤0.01% 6065
2025
Q4 		$171K Sell
10,500
-40,500
-79% -$612K ﹤0.01% 9850
2025
Q3 		$596K Sell
51,000
-24,200
-32% -$316K ﹤0.01% 7468
2025
Q2 		$871K Buy
75,200
+3,300
+5% +$30.1K ﹤0.01% 5871
2025
Q1 		$628K Buy
+71,900
New +$906K ﹤0.01% 6448
2024
Q4 		– Sell
-85,600
Closed -$1.93M – 10628
2024
Q3 		$1.93M Buy
85,600
+68,000
+386% +$1.41M ﹤0.01% 4545
2024
Q2 		$342K Sell
17,600
-14,600
-45% -$382K ﹤0.01% 7594
2024
Q1 		$1.21M Sell
32,200
-92,400
-74% -$4.06M ﹤0.01% 5066
2023
Q4 		$6.97M Sell
124,600
-164,600
-57% -$7.16M ﹤0.01% 2395
2023
Q3 		$11.9M Buy
289,200
+252,800
+695% +$13.2M ﹤0.01% 1588
2023
Q2 		$2.03M Sell
36,400
-70,200
-66% -$3.8M ﹤0.01% 4142
2023
Q1 		$5.95M Buy
106,600
+18,500
+21% +$864K ﹤0.01% 2205
2022
Q4 		$3.21M Buy
88,100
+58,200
+195% +$1.9M ﹤0.01% 3116
2022
Q3 		$852K Buy
29,900
+20,600
+222% +$785K ﹤0.01% 5706
2022
Q2 		$421K Sell
9,300
-49,800
-84% -$2.58M ﹤0.01% 7042
2022
Q1 		$4.5M Buy
59,100
+45,300
+328% +$3.96M ﹤0.01% 3211
2021
Q4 		$2.06M Sell
13,800
-25,200
-65% -$3.86M ﹤0.01% 4431
2021
Q3 		$5.68M Sell
39,000
-32,700
-46% -$5.61M ﹤0.01% 2536
2021
Q2 		$14M Buy
71,700
+68,200
+1,949% +$12.3M 0.01% 1375
2021
Q1 		$634K Sell
3,500
-6,100
-64% -$1.05M ﹤0.01% 6363
2020
Q4 		$1.36M Sell
9,600
-47,900
-83% -$6.95M ﹤0.01% 4166
2020
Q3 		$7.17M Buy
57,500
+4,200
+8% +$441K ﹤0.01% 1496
2020
Q2 		$4.76M Buy
+53,300
New +$4.15M ﹤0.01% 1907

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's TXG Position: Q1 2026 in Review

Jane Street sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 24,155 shares — an estimated $483K sold.

Jane Street first reported a position in TXG in Q3 2019 and held it in 23 quarters. The position peaked at $14.7M in Q3 2020. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Jane Street reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 24,155 10x Genomics shares in Q1 2026, an estimated $483K.
  • Jane Street first reported a position in 10x Genomics in Q3 2019 and held it in 23 quarters.
  • Jane Street's 10x Genomics position peaked at $14.7M in Q3 2020.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.